Untargeted Metabolic Profiling of Cat Urine and Plasma in Hypertension
Open Access
- 1 September 2025
- journal article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 39 (5) , e70227
Abstract
Background: Early diagnosis of hypertension remains an important problem in cats. Lack of routine blood pressure screening in primary care practice, and the possibility of white coat artifact mean the discovery of a new diagnostic test, if less sensitive to short-term changes in blood pressure associated with veterinary care, would be useful. Identification of metabolomic changes in hypertensive cats could advance understanding of the pathogenesis of hypertension in cats, as well as identify novel biomarkers. Objectives: Use untargeted metabolomics to identify biochemical changes in cat plasma and urine between normotensive controls (NT) and hypertensive cats before treatment (HTpre); HTpre and hypertensive cats treated with amlodipine (HTtx). Animals: Biobanked surplus plasma and urine samples were selected from client-owned cats (> 9 years old) that were NT (urine n = 17, plasma n = 19), HTpre (urine n = 13, plasma n = 19), or HTtx (urine n = 12, plasma n = 19). Methods: Samples were profiled using flow infusion electrospray—high-resolution mass spectrometry, and differences assessed using univariate (paired or two sample t-tests) and multivariate (partial least squares discriminant analysis) methods using the R-based MetaboAnalyst platform. Tentative identifications of metabolites then were made using the MZedDb database. Results: Significant (false discovery adjusted < 0.01) biochemical differences were observed between each of the sample groups. Biochemical changes in urine between HTpre and NT animals were linked to the tricarboxylic acid cycle, oxidative stress, steroid hormones, taurine metabolism, and phosphatidylinositol-3,4,5-trisphosphate. Conclusions: Metabolites altered in hypertensive cats were similar to those observed in other species.Keywords
Funding Information
- Biotechnology and Biological Sciences Research Council
- Boehringer Ingelheim
- Biotechnology and Biological Sciences Research Council
- Boehringer Ingelheim
This publication has 66 references indexed in Scilit:
- Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluationJournal of the American Veterinary Medical Association, 2002
- Feline hypertension: clinical findings and response to antihypertensive treatment in 30 casesJournal of Small Animal Practice, 2001
- Ocular lesions associated with systemic hypertension in cats: 69 cases (1985–1998)Journal of the American Veterinary Medical Association, 2000
- Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailabilityJACC, 1999
- Arginine metabolism: nitric oxide and beyondBiochemical Journal, 1998
- Treatment of systemic hypertension in cats with amlodipine besylateJournal of the American Animal Hospital Association, 1997
- Significance of 19-noraldosterone, a new mineralocorticoid, in clinical and experimental hypertensionSteroids, 1995
- Hypertension in Cats With Chronic Renal Failure or HyperthyroidismJournal of Veterinary Internal Medicine, 1990
- Arginine: An Essential Amino Acid for the CatThe Journal of Nutrition, 1978
- Taurine: An Essential Nutrient for the CatThe Journal of Nutrition, 1978